Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huoxiang Zhengqi Oral Liquid for gastrointestinal-type common cold
ChiCTR1800014834Phase 4Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Jul 2017
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Huoxiang Zhengqi in nasopharyngitis (6 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoint: Disease recovery time. Started Jul 2017; status: recruiting.
02
Drugs
Huoxiang Zhengqi
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on ChiCTR1800014834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014834.